MYLAN G2
Pill imprint MYLAN G2 has been identified as Glipizide 10 mg.
Glipizide is used in the treatment of diabetes, type 2 and belongs to the drug class sulfonylureas. Risk cannot be ruled out during pregnancy.
Glipizide 10 mg is not subject to the Controlled Substances Act.
See also related documents.
Glipizide Images
- Imprint:
-
MYLAN G2
- Strength:
- 10 mg
- Color:
- White
- Size:
- 10.00 mm
- Shape:
- Round
- Availability:
- Prescription only
- Inactive Ingredients:
- silicon dioxide colloidal
lactose anhydrous
microcrystalline cellulose
pregelatinized starch
stearic acid
- Drug Class:
- Sulfonylureas
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
- National Drug Code (NDC):
- 00378-1110
| NDC Code | Manufacturer / Repackager |
|---|---|
| 51079-0811 | UDL Laboratories Inc |
| 49999-0107 | Lake Erie Medical and Surgical Supply (repackager) |
Note: Inactive ingredients may vary.
Advertisement
More Glipizide resources
- Glipizide
- Glipizide (Wolters Kluwer)
- Glipizide Extended-Release Tablets (Wolters Kluwer)
- glipizide (Cerner Multum)
- glipizide (Micromedex) - Includes Dosage Information
- Glipizide (AHFS DI)
- Glipizide (FDA)
- Glipizide ER (FDA)
- Glipizide Tablets (FDA)
- Glipizide (Wolters Kluwer)
Search Again
